Oral creatine supplementation: A potential adjunct therapy for rheumatoid arthritis patients

doi:10.5499/wjr.v4.i3.22

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (19514)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

635

WORD

440

HTML

15879

Tables (1-4)

258

Sum=17212

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1116

Download

1186

Sum=2302

Nov 12, 2014 (publication date) through Feb 3, 2025

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Rheumatology

ISSN

2220-3214

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Rheumatol. Nov 12, 2014; 4(3): 22-34
Published online Nov 12, 2014. doi: 10.5499/wjr.v4.i3.22

Table 2 Changes in creatine and phosphocreatine levels following Cr supplementation

	Mean baseline Cr levels¹	Increase after20 g/d for 5 d
Creatine	Approximately 125 mmol· kg/dw[130] (90 to 160 mmol· kg/dw)[4]	+ 25 mmol· kg/dw (approximately 20%)[144]
Phosphocreatine	Approximately 50 mmol· kg/dw[41]	+ 8 mmol· kg/dw (approximately 15%)[132]

¹Typical values for an average 70 kg male. Cr: Creatine.

Citation: Wilkinson TJ, O’Brien TD, Lemmey AB. Oral creatine supplementation: A potential adjunct therapy for rheumatoid arthritis patients. World J Rheumatol 2014; 4(3): 22-34
URL: https://www.wjgnet.com/2220-3214/full/v4/i3/22.htm
DOI: https://dx.doi.org/10.5499/wjr.v4.i3.22